A Microcapsule‐Integrated smRandom‐seq Platform Enables Fixation‐Free Single Microbe RNA Sequencing
Advanced Science · 2026
DOI: 10.1002/advs.77013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Mengdi Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Sequence Analysis, RNA, Escherichia coli, Acinetobacter baumannii, Single-Cell Analysis. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Key R&D Program of Zhejiang, Hangzhou Leading Innovation and Entrepreneurship Team Project.
Abstract (Originalsprache)
Single‐microbe RNA sequencing (smRNA‐seq) emerges as a powerful approach for resolving microbial heterogeneity at single‐cell resolution, but current high‐throughput workflows still depend on chemical fixation to preserve cell‐of‐origin transcriptomic information during lysis, permeabilization, and downstream processing. Although fixation is integral to current smRNA‐seq workflows, its broader impact on overall performance remains unresolved because a practical alternative is lacking. Here, we present an smRNA‐seq strategy that integrates aqueous two‐phase system microcapsules with our previously developed smRandom‐seq method. Using polyethylene glycol diacrylate‐ and dextran‐based microcapsules, our method physically confines bacterial cells and released nucleic acids within individual microcompartments, thereby enabling single‐cell transcript capture in both fixation‐based and fixation‐free workflows. With two model species, Escherichia coli and Acinetobacter baumannii , we show that fixation‐free processing improves smRNA‐seq performance, increasing per‐cell gene detection sensitivity by approximately 50% relative to fixed controls while preserving similar overall transcriptional profiles. To our knowledge, this microcapsule‐integrated smRandom‐seq platform achieves the highest transcriptomic capture sensitivity among current high‐throughput smRNA‐seq platforms. This framework provides a practical alternative to fixation in high‐throughput smRNA‐seq and opens new prospects for the development of single‐microbe omics technologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.
- M20 Genomics, Hangzhou, China.
- College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, China.
ORCID-Profile: Zhengmin Tang, Yongcheng Wang
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Key R&D Program of Zhejiang
- Hangzhou Leading Innovation and Entrepreneurship Team Project
Zitieren
APA
Song, M., Wang, Y., Wang, Z., Zhang, S., Tang, Z., & Wang, Y. (2026). A Microcapsule‐Integrated smRandom‐seq Platform Enables Fixation‐Free Single Microbe RNA Sequencing. Advanced Science. https://doi.org/10.1002/advs.77013
Vancouver
Song M, Wang Y, Wang Z, Zhang S, Tang Z, Wang Y. A Microcapsule‐Integrated smRandom‐seq Platform Enables Fixation‐Free Single Microbe RNA Sequencing. Advanced Science. 2026. doi:10.1002/advs.77013
BibTeX
@article{Song2026,
author = {Song, Mengdi and Wang, Yuting and Wang, Zhaolun and Zhang, Shunji and Tang, Zhengmin and Wang, Yongcheng},
title = {A Microcapsule‐Integrated smRandom‐seq Platform Enables Fixation‐Free Single Microbe RNA Sequencing},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.77013}
}
EUVIMED